CLINICAL ROLE -
Use of Multiple Sclerosis Disease-Modifying Therapies During COVID-19 Pandemic
In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.
Read More